Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Lori Sakoda   and   Laurel Habel.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.433
         
        
        
     
 
    
        
        - 
            Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
            
            
                Score: 0.481
            
         
        
        - 
            Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
            
            
                Score: 0.183
            
         
        
        - 
            Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nat Commun. 2020 10 09; 11(1):5116.
            
            
                Score: 0.178
            
         
        
        - 
            Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members. Lung Cancer. 2018 Nov; 125:51-56.
            
            
                Score: 0.154
            
         
        
        - 
            HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013 Mar 14; 15(2):R24.
            
            
                Score: 0.106
            
         
        
        - 
            MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer. Nat Commun. 2023 Jan 23; 14(1):377.
            
            
                Score: 0.052
            
         
        
        - 
            Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies. BMC Med. 2022 10 06; 20(1):332.
            
            
                Score: 0.051
            
         
        
        - 
            A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Res. 2021 04 01; 81(7):1695-1703.
            
            
                Score: 0.045
            
         
        
        - 
            Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
            
            
                Score: 0.044
            
         
        
        - 
            Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):1039-1048.
            
            
                Score: 0.043
            
         
        
        - 
            Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
            
            
                Score: 0.035
            
         
        
        - 
            A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
            
            
                Score: 0.031
            
         
        
        - 
            Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
            
            
                Score: 0.030